This document is a medical report from BioReference Laboratories for Jeffrey Epstein, dated July 23, 2016. It includes various clinical test results such as chemistry, hematology, urinalysis, and hormone levels. Some tests were not performed due to specimen rejection caused by hemolysis. The report indicates abnormal levels in several tests, including high cholesterol, triglycerides, and ALT levels, as well as low HDL cholesterol. The report also includes a probability assessment for prostate cancer based on PSA levels.
documents/EFTA00582641.pdf
{}